Principal results of the Controlled Onset Verapamil Investigation of Cardiovascular End Points (CONVINCE) trial.
Black HR, Elliott WJ, Grandits G, Grambsch P, Lucente T, White WB, Neaton JD, Grimm RH Jr, Hansson L, Lacourciere Y, Muller J, Sleight P, Weber MA, Williams G, Wittes J, Zanchetti A, Anders RJ; CONVINCE Research Group.
Black HR, et al. Among authors: neaton jd.
JAMA. 2003 Apr 23-30;289(16):2073-82. doi: 10.1001/jama.289.16.2073.
JAMA. 2003.
PMID: 12709465
Clinical Trial.